3626 results for «499»

Filter By

3626 results

Left main multivessel disease and other coronary interventions

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session will allow you to study a rare case of coronary artery dissection due to blunt chest trauma leading to myocardial infarction, the evolution from LAD to LMS stenting, the use of a mini-crush for a complex left main bifurcation, and much more!

Left main multivessel disease and other coronary interventions

Gulf WIN - Opportunities and challenges

15 Dec 2022 – From GulfPCR-GIM 2022

Women have the floor in this special GulfPCR-GIM 2022 session: hear from members of the Gulf WIN (Women In Intervention) to better understand the status of women interventionists in the region, explore the challenges they face, and note the differences that exist with other women cardiologists...

Gulf WIN - Opportunities and challenges

Left main and multivessel disease - Session 1

15 Dec 2022 – From GulfPCR-GIM 2022

Consult this session on left main and multivessel disease to discover a selection of cases presented during Gulf PCR 2022: multiple bifurcation lesions in an octogenarian and high-bleeding risk case, left anterior descending CTO complicated by left main thrombus with left main trifurcation stenting, and much more!

Left main and multivessel disease - Session 1

Optimal management of a patient with calcified lesions - Session with LIVE case

15 Dec 2022 – From GulfPCR-GIM 2022

Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.

Optimal management of a patient with calcified lesions

Essential drugs that every interventionalist needs to know

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.

Essential drugs that every interventionalist needs to know

Rapid-fire clinical cases: Session 4

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...

Rapid-fire clinical cases: Session 4

Mitral edge-to-edge repair: challenging cases

Watch an acute papillary muscle rupture with torrential mitral regurgitation, a transcatheter mitral edge-to-edge repair in recurrent mitral regurgitation after Alfieri stitch, and several other exciting challenging cases in this PCR LV 2022 session!

Mitral edge-to-edge repair: challenging cases

Improving the equity of access to percutaneous valve interventions: EAPCI initiatives for patients and health care professionals

28 Nov 2022 – From PCR London Valves 2022

Consul this session if you want to understand current unmet needs in the field of transcatheter valve intervention, to appraise the impact of the Valve for Life initiative on adoption of TAVI across Europe, and to hear about the new EAPCI Core Curriculum for training in...

Improving the equity

PCR London Valves 2022 Closing Ceremony

29 Nov 2022 – From PCR London Valves 2022

Bernard Prendergast and the Faculty members celebrate the end of another fantastic edition of PCR London Valves which focused on learning, sharing, training and networking in a friendly environment.

View key facts, figures and great snapshots of what went on during these inspiring 3 days: the best-of #PCRLV...

PCR London Valves 2022 Closing Ceremony

PCR London Valves 2022 Welcome Ceremony

27 Nov 2022 – From PCR London Valves 2022

Consult this session to watch PCR LV 2022 Welcome Ceremony, and learn more about the track leaders, the programme producers, as well as the latest updates regarding this congress.

PCR London Valves 2022 Welcome Ceremony

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!

18 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...

EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

Start treating refractory angina patients with Reducer therapy - Practical aspects

17 May 2022 – From EuroPCR 2022

Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...

Start treating refractory angina patients with Reducer therapy - Practical aspects

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!

18 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!

DCB and the possibility of a clean vessel

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...

DCB and the possibility of a clean vessel

2022: a tipping point in the treatment of mitral regurgitation patients

17 May 2022 – From EuroPCR 2022

With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

2022: a tipping point in the treatment of mitral regurgitation patients

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...

How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions
Didn’t find what you were looking for?